NTLA
Intellia Therapeutics Inc
12.30$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 71.9% | 76.7% | 70.2% | 63.5% | 60.6% | 53.7% | 55.9% | 55.2% | 62.9% | 62.7% | 61.5% | 61.6% | |
| 13.5% | 17.4% | 13.7% | 11.0% | 10.3% | 15.9% | 12.9% | 17.4% | 20.9% | 18.5% | 17.8% | 12.4% | |
| 68.7% | 70.1% | 62.8% | 58.0% | 56.1% | 50.5% | 51.1% | 51.1% | 55.2% | 53.4% | 49.6% | 51.1% | |
| 0.5% | 2.8% | 2.9% | 1.0% | 0.8% | 0.7% | 1.1% | 1.3% | 1.2% | 1.1% | 1.2% | 0.9% | |
| -11.1% | – | 0.0% | – | – | – | – | – | – | – | – | – | |
| 16.6% | 19.3% | 17.7% | 18.5% | 18.0% | 26.8% | 20.9% | 20.4% | 19.1% | 20.3% | 18.2% | 15.1% | |
| 7.4% | 8.9% | 7.8% | 8.8% | 9.0% | 9.3% | 11.4% | 10.6% | 10.1% | 12.3% | 10.1% | 9.3% | |
| 1.4% | 1.4% | 1.5% | 1.6% | 1.6% | 1.7% | 3.9% | 3.0% | 3.0% | 3.1% | 2.5% | 2.7% | |
| 0.3% | 0.6% | 1.1% | 1.6% | 1.1% | 1.2% | 1.3% | 1.1% | 1.4% | 2.4% | 2.5% | 1.4% | |
| 83.4% | 80.7% | 82.3% | 81.5% | 82.0% | 73.2% | 79.1% | 79.6% | 80.9% | 79.7% | 81.8% | 84.9% | |
| -122.8% | -127.5% | -140.2% | -160.5% | -174.6% | -182.8% | -232.4% | -266.2% | -269.6% | -307.6% | -354.0% | -325.8% | |
| 7.1% | 7.0% | 7.6% | 8.1% | 8.6% | 8.6% | 10.5% | 11.5% | 11.9% | 12.9% | 15.6% | 15.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.